The board of directors of DTXS Silk Road Investment Holdings Company Limited announced the following change of directors and change in composition of board committee with effect from 1 February 2023: Mr. Sun Liming (Mr. Sun), has been appointed as an Executive Director, a Co-Chief Executive Office (the Co-CEO) and the Chairman of the Investment Committee of the Company with effect from 1 February 2023. He will focus on financial management and administrative operations of the Company and its subsidiaries (the "Group"). Mr. Sun, aged 69, holds a bachelor's degree in Management Engineering from Xian Jiaotong University in the People's Republic of China.

Mr. Sun is a director of Da Tang Xi Shi International Holdings Limited, immediate controlling shareholder of the Company. He has more than 30 years of experience in corporate planning and economic and financial management. Mr. Sun is currently an independent non-executive director of Yanchang Petroleum International Limited.

Following the appointment of Mr. Sun as a Co-CEO, Mr. Wong Kwok Tung Gordon Allan (Mr. Wong), an Executive Director, the Deputy Chief Executive Officer and a member of the Investment Committee of the Company, has been re-designated as a Co-CEO with effect from 1 February 2023. Mr. Wong also has been appointed as an Authorised Representative of the Company with effect from 1 February 2023. He was previously re-designated from the chief executive officer to the deputy chief executive officer of the Company on 7 August 2017 and resigned as a member of the Remuneration Committee of the Company on 28 March 2018.

His position of Executive Director and member of the Investment Committee of the Company remains unchanged. Mr. Wong will focus on the investment and financing operation and continue to closely work with the management team towards the Group's business development. Dr. Xu Zhihong (Dr. Xu) has resigned as an Executive Director and an Executive Vice-chairman of the Company, also has ceased as the Chairman of the Investment Committee and an Authorised Representative of the Company in order to devote more time to his other business engagements with effect from 1 February 2023.

Dr. Xu confirmed that he has no disagreement with the Board in regarding to the business and operations of the Company and there is no other matter in relation to his resignation that needs to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited.